Interestingly, a study by Collins et al. found that MAP4K4 knockdown successfully inhibited the migration of multiple carcinoma cell lines, highlighting its role in cell motility and the therapeutic potential of targeting the MAPK pathway in cancer progression. The gene discussed is MAP4K4; the disease is cancer.